Last reviewed · How we verify

NCT06835673: HADS

The ICU is a Complex Setting Where Critically Ill Patients Are Treated, Impacting Caregivers' Mental Health, Leading to Anxiety and Depression .we Aim to Identify the Prevalence of Anxiety and Depression Among Family Members of ICU Patients in a Tertiary-Level Hospital in Nepal

Completed Last updated 19 February 2025
What this trial tests

trial in Anxiety Disorder/Anxiety State in 110 participants. Completed in 22 November 2024.

Timeline
1 August 2024
Primary endpoint
22 November 2024
22 November 2024

Quick facts

Lead sponsorTribhuvan University Teaching Hospital, Institute Of Medicine.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date1 August 2024
Primary completion22 November 2024
Estimated completion22 November 2024
Sites1 location across Nepal

Conditions studied

Sponsor

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Who can join

Eligibility, any sex, with Anxiety Disorder/Anxiety State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

a prospective observational study conducted in ICU of tertiary hospital under the guidance of mentors of department of critical care medicine TUTH to identify the Prevalence of Anxiety and Depression Among Family Members of ICU Patients in a Tertiary-Level Hospital in Nepal

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety Disorder/Anxiety State

Currently open trials in the same condition.

Other Tribhuvan University Teaching Hospital, Institute Of Medicine. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06835673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing